Dong-mei Zhang
Dalian, 116044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Transforming growth factor-β-activated kinase 1 and pathological myocardial hypertrophy
Journal: Sheng li xue bao : [Acta physiologica Sinica]
Published: August 21, 2020
Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension.
Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension.
Journal: Cardiovascular toxicology
Published: July 12, 2015
Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.
Journal: Toxicology and applied pharmacology
Published: November 18, 2014
Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction.
Journal: Basic research in cardiology
Published: November 04, 2014
Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension.
Journal: Toxicology and applied pharmacology
Published: February 02, 2014
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
Journal: Toxicology and applied pharmacology
Published: August 27, 2013
Chemokine fractalkine attenuates overactivation and apoptosis of BV-2 microglial cells induced by extracellular ATP.
Journal: Neurochemical research
Published: October 09, 2012
Renin-angiotensin system modulates neurotransmitters in the paraventricular nucleus and contributes to angiotensin II-induced hypertensive response.
Journal: Cardiovascular toxicology
Published: September 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026